Dr. Rojas-Quintero is researching how Metformin, a long-used diabetes drug, may be able to slow fibrosis in the lungs.

The biologic dosed every 2 weeks reduced moderate or severe COPD exacerbations over 52 weeks by a relative 15.4% compared ...

In COPD, patient initiation and persistent use of guideline-concordant maintenance inhaled medications is subpar.

The disappointing result means that AZ will be unable to follow in the footsteps of GSK, whose IL-5 inhibitor Nucala ...

A new COPD drug, developed by Verona Pharma, was approved by the FDA Wednesday. The drug, ensifentrine, is the first new type of maintenance treatment for COPD in over a decade. In clinical trials, ...

Cytisinicline significantly increases quit rates in smokers with or without COPD while being safe and well tolerated.

An EHR-embedded inpatient care pathway for COPD was tied to improved adherence to evidence-based practices, shorter hospital ...

The top 5 most-read chronic obstructive pulmonary disease (COPD) articles of 2024 covered topics such as inhaled medication risks, gabapentinoid use, and the link between high white blood cell counts ...

Among patients with COPD, at least 50% reported that the disease impacts their daily life and emotional health, according to ...

Veterans with COPD and current tobacco use faced a reduced likelihood for tobacco dependence treatment if they lived in a ...

Singing can improve the quality of life of people with lung disease and help reduce their symptoms, according to a gold-standard randomzed-controlled trial presented at the Congress in Amsterdam, the ...